Medication Safety

Responding to medication incidents

26 June 2026Practical guidance to support those responding to medication incidents.

Managing fire risk with emollients and other skin products

24 June 2026Emollient residue can increase the risk of fatal burns. This article outlines how fire risk occurs, which patients may be at increased risk, and harm reduction.

Managing the risk of confusion between injectable iron products

22 June 2026Minimising the risk of confusion between different injectable iron products may prevent inadvertent harm.

Supporting safe use of adrenal crisis emergency management kits

22 June 2026Treatment of adrenal crisis is time critical and relies on timely use of injectable hydrocortisone to prevent harm.

Prescribing and administering intravenous paracetamol safely

22 June 2026Guidance on safe prescribing and administration of IV paracetamol, including dosing, infusion, risk mitigation, and monitoring to prevent errors.

Managing the risk of confusion between insulin products

8 June 2026Increased awareness and embedding processes for safer use may reduce the risk of mis-selection and harms associated with insulin use.

Developing Medication Safety Across The System (MSATS)

4 June 2026Medication Safety Across the System (MSATS) provides resources and networking to inspire and equip individuals in promoting the safe use of medicines.

Medication Safety Update

2 June 2026A resource collating the latest medication safety communications and publications to inform, support and inspire medication safety improvements.

Use of injectable medicines for multiple doses

27 May 2026Using injectable medicines for multiple doses increases the risk of contamination, error and patient harm.

Benztropine injection for acute dystonic reactions

20 May 2026SPS has developed this resource to support healthcare professionals in managing the discontinuation of procyclidine injection.